Abeona Therapeutics
Madhav Vasanthavada joined Abeona with over 20 years of experience in the life sciences industry, in a variety of scientific and commercial leadership roles. Dr. Vasanthavada was most recently at Bristol Myers Squibb, where he led Global Marketing for the Global Car T Cell Therapy Franchise. Prior to BMS, he spent 9 years at Bayer in a variety of cross-functional leadership roles, including Marketing, Market Access, Sales and Chief of Staff to the Bayer President of the Americas. Earlier in his career, Dr. Vasanthavada also served as a Principal Scientist at Novartis in Research & Development and Technical Operations.
He holds a B.S. in Pharmacy from Osmania University, a Ph.D. in Pharmaceutical Sciences from the University of Rhode Island, and an M.B.A. from Harvard Business School.
This person is not in any offices
Abeona Therapeutics
1 followers
Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine.